Peripheral Arterial Disease: Features
Original Research
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
Clinical Editor's Corner
03/17/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary...
03/17/2026
Vascular Disease Management
ISET 2026
03/12/2026
Marianne Brodmann, MD
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results of the TRUE-PTX study, which compared paclitaxel drug-eluting and bare device treatment for PAD using real-world data design.
Dr. Brodmann reviews the results...
03/12/2026
Vascular Disease Management
Interview
03/11/2026
Srini Tummala, MD
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the...
03/11/2026
Vascular Disease Management
Sponsored Video
03/05/2026
Michael Siah, MD; Zola N'Dandu, MD; Khanjan Nagarsheth, MD, MBA, RPVI
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option” truly means, to understanding the role of small artery disease and medial arterial calcification in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
From redefining what “no-option”...
03/05/2026
Vascular Disease Management
ISET 2026
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
ISET 2026
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
ISET 2026
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
LINC 2026
01/29/2026
Francesco Liistro, MD
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a pragmatic, mechanics-first approach to DCB therapy in BTK arteries.
Dr Francesco Liistro shares a...
01/29/2026
Vascular Disease Management
LINC 2026
01/29/2026
Tatsuya Nakama, MD
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how device design, paclitaxel dose, and meticulous lesion preparation may shape long-term durability in everyday practice.
Dr Tatsuya Nakama discusses how...
01/29/2026
Vascular Disease Management
